JP2023011735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023011735A5 JP2023011735A5 JP2022171542A JP2022171542A JP2023011735A5 JP 2023011735 A5 JP2023011735 A5 JP 2023011735A5 JP 2022171542 A JP2022171542 A JP 2022171542A JP 2022171542 A JP2022171542 A JP 2022171542A JP 2023011735 A5 JP2023011735 A5 JP 2023011735A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- dry eye
- trifluoromethylchroman
- tetrahydronaphthalen
- ylidene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019184053 | 2019-10-04 | ||
| JP2019184053 | 2019-10-04 | ||
| JP2022017196A JP7248836B2 (ja) | 2019-10-04 | 2022-02-07 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017196A Division JP7248836B2 (ja) | 2019-10-04 | 2022-02-07 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023011735A JP2023011735A (ja) | 2023-01-24 |
| JP2023011735A5 true JP2023011735A5 (enExample) | 2023-10-04 |
Family
ID=75338162
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541679A Active JP7025094B2 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2022017196A Active JP7248836B2 (ja) | 2019-10-04 | 2022-02-07 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2022171542A Pending JP2023011735A (ja) | 2019-10-04 | 2022-10-26 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541679A Active JP7025094B2 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2022017196A Active JP7248836B2 (ja) | 2019-10-04 | 2022-02-07 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220370404A1 (enExample) |
| EP (2) | EP4043014B1 (enExample) |
| JP (3) | JP7025094B2 (enExample) |
| KR (1) | KR20220078604A (enExample) |
| CN (1) | CN114585357A (enExample) |
| AU (1) | AU2020361093A1 (enExample) |
| BR (1) | BR112022005992A2 (enExample) |
| CA (1) | CA3156484A1 (enExample) |
| DK (1) | DK4043014T3 (enExample) |
| ES (1) | ES3031607T3 (enExample) |
| HU (1) | HUE072085T2 (enExample) |
| MX (2) | MX2022004027A (enExample) |
| MY (1) | MY207759A (enExample) |
| PH (1) | PH12022550805A1 (enExample) |
| PL (1) | PL4043014T3 (enExample) |
| PT (1) | PT4043014T (enExample) |
| WO (1) | WO2021066144A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220078604A (ko) * | 2019-10-04 | 2022-06-10 | 센주 세이야꾸 가부시키가이샤 | 헤테로시클리덴아세트아미드 유도체 함유 의약 |
| MX2023011649A (es) * | 2021-03-30 | 2023-10-11 | Senju Pharma Co | Suspension que contiene derivado de heterociclidenacetamida. |
| WO2024071349A1 (ja) | 2022-09-29 | 2024-04-04 | 千寿製薬株式会社 | ヘテロシクリデンアセトアミド誘導体を含む配合剤 |
| WO2024071348A1 (ja) | 2022-09-29 | 2024-04-04 | 千寿製薬株式会社 | 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5621566A (en) | 1979-08-01 | 1981-02-28 | Alpha- Shokuhin Kk | Preparation of bifun from homegrown rice and apparatus used for it |
| CA2616079C (en) * | 2005-07-22 | 2012-09-25 | Mochida Pharmaceutical Co., Ltd. | Novel heterocyclidene acetamide derivative |
| ZA200800959B (en) * | 2005-07-22 | 2009-10-28 | Mochida Pharmaceutical Company | Novel heterocyclidene acetamide derivative |
| TW200927192A (en) | 2007-11-19 | 2009-07-01 | Alcon Res Ltd | Use of TRPV1 receptor antagonists for treating dry eye and ocular pain |
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| EP2377850A1 (en) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
| WO2012045729A1 (en) * | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists |
| GB201215857D0 (en) * | 2012-09-05 | 2012-10-24 | Sylentis Sau | siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| JP6230743B1 (ja) | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| JP7373909B2 (ja) | 2018-04-06 | 2023-11-06 | 株式会社シマノ | 変速制御装置および変速システム |
| KR20220078604A (ko) * | 2019-10-04 | 2022-06-10 | 센주 세이야꾸 가부시키가이샤 | 헤테로시클리덴아세트아미드 유도체 함유 의약 |
-
2020
- 2020-10-02 KR KR1020227012080A patent/KR20220078604A/ko active Pending
- 2020-10-02 PT PT208720615T patent/PT4043014T/pt unknown
- 2020-10-02 BR BR112022005992A patent/BR112022005992A2/pt unknown
- 2020-10-02 CA CA3156484A patent/CA3156484A1/en active Pending
- 2020-10-02 AU AU2020361093A patent/AU2020361093A1/en active Pending
- 2020-10-02 CN CN202080069192.5A patent/CN114585357A/zh active Pending
- 2020-10-02 PH PH1/2022/550805A patent/PH12022550805A1/en unknown
- 2020-10-02 HU HUE20872061A patent/HUE072085T2/hu unknown
- 2020-10-02 DK DK20872061.5T patent/DK4043014T3/da active
- 2020-10-02 EP EP20872061.5A patent/EP4043014B1/en active Active
- 2020-10-02 PL PL20872061.5T patent/PL4043014T3/pl unknown
- 2020-10-02 US US17/766,090 patent/US20220370404A1/en active Pending
- 2020-10-02 JP JP2021541679A patent/JP7025094B2/ja active Active
- 2020-10-02 MY MYPI2022001736A patent/MY207759A/en unknown
- 2020-10-02 WO PCT/JP2020/037548 patent/WO2021066144A1/ja not_active Ceased
- 2020-10-02 MX MX2022004027A patent/MX2022004027A/es unknown
- 2020-10-02 ES ES20872061T patent/ES3031607T3/es active Active
- 2020-10-02 EP EP25164201.3A patent/EP4545095A3/en active Pending
-
2022
- 2022-02-07 JP JP2022017196A patent/JP7248836B2/ja active Active
- 2022-04-01 MX MX2025005474A patent/MX2025005474A/es unknown
- 2022-10-26 JP JP2022171542A patent/JP2023011735A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023011735A5 (enExample) | ||
| JP2022065024A5 (enExample) | ||
| JP2023017050A5 (enExample) | ||
| JP2017222722A5 (enExample) | ||
| JP2010280708A5 (enExample) | ||
| JP2019137703A5 (enExample) | ||
| JP2012520249A5 (enExample) | ||
| IL263314A (en) | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases | |
| JP2014525426A5 (enExample) | ||
| JP2018035160A5 (enExample) | ||
| JP2023098936A5 (enExample) | ||
| JP2014502979A5 (enExample) | ||
| JP2017528507A5 (enExample) | ||
| JP2014062126A5 (enExample) | ||
| JP2011516477A5 (enExample) | ||
| JP2017528503A5 (enExample) | ||
| JP2020138980A5 (enExample) | ||
| JP2014533274A5 (enExample) | ||
| JP2013500977A5 (enExample) | ||
| MX2021010133A (es) | Forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifl uorometil)-n-(2-(trifluorometil)piridin-4-il)-1h-pirazol-4-carbox amida monohidratada. | |
| JP2019519533A5 (enExample) | ||
| JP2020514283A5 (enExample) | ||
| JP2017522300A5 (enExample) | ||
| JPWO2023195530A5 (enExample) | ||
| JP2019052163A5 (enExample) |